Digital IBS care startup metaMe Health is launching its recently FDA-approved prescription digital therapeutic using a partnership with operations and commercialization company Indegene.
Regulora, which scored an FDA 510(k) late last year, delivers gut-directed hypnotherapy to help alleviate pain associated with IBS in adults. As part of the commercialization deal, Indegene will focus on bringing...
Woebot Health, maker of an AI-powered mental health chatbot, announced Tuesday it has raised $9.5 million from Leaps by Bayer.
The strategic investment comes about eight months after the company said it had scored $90 million in Series C funding. Last year, Woebot received FDA Breakthrough Device Designation for its digital therapeutic treating postpartum depression.
"Woebot Health’s mission and...
metaMe Health has received FDA 510(k) clearance for Regulora, a prescription digital therapeutic aimed at treating abdominal pain associated with irritable bowel syndrome in adults.
Regulora is a smartphone app that delivers behavioral therapy based on gut-directed hypnotherapy to alleviate IBS pain.
“The FDA’s clearance of Regulora, our first PDT, is a major achievement for the company,” Tim...
Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers.
WHAT THEY DO
The company’s lead product is Regulora, a treatment tackling the cognitive, behavioral and affective factors that can trigger...
